Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Evolent (NYSE: EVH) will release its third quarter 2025 financial results on Thursday, November 6, 2025 after market close, followed by a conference call at 5:00 p.m. ET.
Shareholders can listen live and access an audio replay for 90 days on Evolent's investor relations website. Analysts may join the live Q&A via domestic dial-in 855.940.9467 or international 412.317.6034 (reference: "Evolent call").
Management will also present at upcoming investor conferences: UBS Global Healthcare in Palm Beach Gardens on Nov 11, 2025, Stephens Investment in Nashville on Nov 18, 2025, and Piper Sandler Healthcare in New York from Dec 2–4, 2025. Live audio webcasts and replays will be posted in the Events and Presentations section of the investor site as times become available.
Evolent (NYSE: EVH) pubblicherà i suoi risultati del terzo trimestre 2025 giovedì 6 novembre 2025 dopo la chiusura del mercato, seguito da una conference call alle 17:00 ET.
Gli azionisti possono ascoltare in diretta e accedere a una replica audio per 90 giorni sul sito degli investitori di Evolent. Gli analisti possono partecipare alla sessione di domande e risposte in diretta tramite numero domestico 855.940.9467 o internazionale 412.317.6034 (riferimento: "Evolent call").
La direzione sarà presente anche a prossimi eventi di investimento: UBS Global Healthcare a Palm Beach Gardens il 11 nov 2025, Stephens Investment a Nashville il 18 nov 2025, e Piper Sandler Healthcare a New York dal 2 al 4 dic 2025. Le dirette audio e le repliche saranno pubblicate nella sezione Eventi e Presentazioni del sito investitori man mano che diventano disponibili.
Evolent (NYSE: EVH) compartirá sus resultados financieros del tercer trimestre de 2025 el jueves 6 de noviembre de 2025 después del cierre del mercado, seguido de una llamada de conferencia a las 5:00 p.m. ET.
Los accionistas pueden escuchar en directo y acceder a una reproducción de audio durante 90 días en el sitio de relaciones con inversores de Evolent. Los analistas pueden unirse a la sesión de preguntas y respuestas en vivo mediante marcación doméstica 855.940.9467 o internacional 412.317.6034 (referencia: "Llamada Evolent").
La dirección también se presentará en próximas conferencias para inversores: UBS Global Healthcare en Palm Beach Gardens el 11 nov 2025, Stephens Investment en Nashville el 18 nov 2025, y Piper Sandler Healthcare en Nueva York del 2 al 4 dic 2025. Las transmisiones en vivo y las repeticiones estarán disponibles en la sección Eventos y Presentaciones del sitio de inversores a medida que estén disponibles.
Evolent (NYSE: EVH)는 2025년 3분기 실적을 2025년 11월 6일 목요일 장 마감 후 발표하고, 동시에 오후 5시(동부 표준시)에 컨퍼런스 콜이 이어집니다.
주주들은 실시간으로 청취하고 Evolent의 투자자 관계 웹사이트에서 90일간의 오디오 리플레이에 접속할 수 있습니다. 애널리스트는 국내 전화번호 855.940.9467 또는 국제 전화번호 412.317.6034로 라이브 Q&A에 참여할 수 있습니다(참고: "Evolent call").
경영진은 또한 다가오는 투자자 컨퍼런스에 참여합니다: UBS Global Healthcare가 Palm Beach Gardens에서 2025년 11월 11일, Stephens Investment가 내슈빌에서 2025년 11월 18일, Piper Sandler Healthcare가 뉴욕에서 2025년 12월 2-4일에 개최됩니다. 라이브 오디오 웹캐스트 및 리플레이는 시간이 공개될 때 투자자 사이트의 행사 및 프리젠테이션 섹션에 게시됩니다.
Evolent (NYSE: EVH) publiera ses résultats du troisième trimestre 2025 le jeudi 6 novembre 2025 après la clôture du marché, suivis d'une conférence téléphonique à 17h00 ET.
Les actionnaires peuvent écouter en direct et accéder à une réplique audio pour 90 jours sur le site des relations investisseurs d'Evolent. Les analystes peuvent rejoindre la séance de questions-réponses en direct via le numéro national 855.940.9467 ou international 412.317.6034 (référence: "Evolent call").
La direction participera également à des conferencess investisseurs à venir : UBS Global Healthcare à Palm Beach Gardens le 11 nov. 2025, Stephens Investment à Nashville le 18 nov. 2025, et Piper Sandler Healthcare à New York du 2 au 4 déc. 2025. Des webdiffusions audio en direct et des replays seront publiés dans la section Événements et Présentations du site investisseurs au fur et à mesure que les horaires sont disponibles.
Evolent (NYSE: EVH) wird seine Ergebnisse des dritten Quartals 2025 am Donnerstag, 6. November 2025 nach Börsenschluss bekannt geben, gefolgt von einer Telefonkonferenz um 17:00 Uhr ET.
Aktionäre können live zuhören und eine Audio-Wiederholung für 90 Tage auf der Investor-Relations-Website von Evolent abrufen. Analysten können sich über die nationale Durchwahl 855.940.9467 oder international 412.317.6034 dem Live-Q&A anschließen (Verweis: "Evolent call").
Das Management wird auch bei kommenden Investorenkonferenzen auftreten: UBS Global Healthcare in Palm Beach Gardens am 11. Nov. 2025, Stephens Investment in Nashville am 18. Nov. 2025, und Piper Sandler Healthcare in New York vom 2.–4. Dez. 2025. Live-Audio-Webcasts und Replays werden im Bereich Events und Presentations der Investoren-Website veröffentlicht, sobald Zeiten verfügbar sind.
Evolent (NYSE: EVH) ستصدر نتائجها المالية للربع الثالث من عام 2025 في الخميس 6 نوفمبر 2025 بعد إغلاق السوق، يتبعها مكالمة مؤتمر في الساعة 5:00 مساءً بتوقيت شرق الولايات المتحدة.
يمكن للمساهمين الاستماع مباشرة والوصول إلى إعادة صوتية لمدة 90 يوماً على موقع العلاقات مع المستثمرين الخاص بـ Evolent. يمكن للمحللين الانضمام إلى جلسة الأسئلة والأجوبة المباشرة عبر الرقم المحلي 855.940.9467 أو الدولي 412.317.6034 (مرجع: "Evolent call").
سيحضر المديرون أيضاً في مؤتمرات المستثمرين القادمة: UBS Global Healthcare في Palm Beach Gardens في 11 نوفمبر 2025، Stephens Investment في Nashville في 18 نوفمبر 2025، و Piper Sandler Healthcare في نيويورك من 2-4 ديسمبر 2025. ستُنشَر البثوث الصوتية المباشرة والتسجيلات في قسم الفعاليات والعروض على موقع المستثمرين كلما توفرت الأوقات.
Evolent (NYSE: EVH) 将在 2025年第三季度 财报公布后于 2025年11月6日星期四 收盘后发布，并在 东部时间17:00 举行电话会议。
股东可以在 Evolent 的投资者关系网站在线观看视频并获得 90 天 的音频回放。分析师可通过国内拨号 855.940.9467 或国际拨号 412.317.6034（参考："Evolent call"）参加现场问答环节。
管理层还将出席即将举行的投资者会议：UBS Global Healthcare 将于 2025年11月11日 在 Palm Beach Gardens 举办，Stephens Investment 将于 2025年11月18日 在纳什维尔，Piper Sandler Healthcare 将于 2025年12月2-4日 在纽约举行。现场音频网络直播及回放将在投资者网站的“活动与演示”部分发布，时间一旦确定即公布。
- None.
- None.
Company to Participate in Upcoming Conferences
Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.
Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.
An audio playback of the conference call will be available on Evolent's investor relations website for 90 days after the call.
Upcoming Investor Events
Additionally, Evolent announced that members of its executive management team will participate in upcoming investor conferences.
A live audio-only webcast and replay for these events will be available on the "Events and Presentations" section of Evolent's investor relations website. Presentation webcast times will be posted on the website as they become available.
- UBS Global Healthcare Conference at the PGA National Resort in
Palm Beach Gardens, Florida on November 11, 2025. - Stephens Investment Conference at the Grand Hyatt in
Nashville, Tennessee on November 18, 2025. - Piper Sandler 37th Annual Healthcare Conference in
New York, New York from December 2-4, 2025.
About Evolent
Evolent specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting https://ir.evolent.com.
Contacts:
investorrelations@evolent.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-to-release-third-quarter-2025-financial-results-on-thursday-november-6-2025-302579115.html
SOURCE Evolent Health, Inc.
FAQ
When will Evolent (EVH) report Q3 2025 results?
What time is the Evolent (EVH) Q3 2025 conference call and how can I listen?
How can analysts join the Evolent (EVH) Q3 2025 live Q&A?
How long will the Evolent (EVH) Q3 2025 call replay remain available?
When and where will Evolent (EVH) management present at investor conferences in late 2025?
Where can investors find replays and presentation materials for Evolent (EVH) conference events?
